Cytogenetic studies include metaphase and pro-metaphase studies carried out on lymphocytes to detect chromosomal aberrations associated with structural and numerical abnormalities. Lymphocytes come from normal peripheral blood and are mitotically inactive, hence have to be stimulated with a mitogen such as Phytohemagglutinin M(PHA-M) or Phytohemagglutinin P(PHA-P). AL249A is composed of a basal medium RPMI 1640 and supplemented with L-glutamine, FBS, PHA-P, penicillin, streptomycin and sodium bicarbonate. It is a complete medium and does not require supplementation with any additional components.
Technical Data Sheet (TD)
HiKaryoXL™ RPMI Medium w/ L-Glutamine, FBS, PHA-P, Penicillin, Streptomycin and Sodium bicarbonate
Safety Data Sheet (SDS)
HiKaryoXL™ RPMI Medium w/ L-Glutamine, FBS, PHA-P, Penicillin, Streptomycin and Sodium bicarbonate
Electronic Instructions for Use (eIFU)
HiKaryoXL™ RPMI Medium w/ L-Glutamine, FBS, PHA-P, Penicillin, Streptomycin and Sodium bicarbonate
HiKaryoXL™ RPMI Medium w/ L-Glutamine, FBS, PHA-P, Penicillin, Streptomycin and Sodium bicarbonate
Cytogenetic studies include metaphase and pro-metaphase studies carried out on lymphocytes to detect chromosomal aberrations associated with structural and numerical abnormalities. Lymphocytes come from normal peripheral blood and are mitotically inactive, hence have to be stimulated with a mitogen such as Phytohemagglutinin M(PHA-M) or Phytohemagglutinin P(PHA-P). AL249A is composed of a basal medium RPMI 1640 and supplemented with L-glutamine, FBS, PHA-P, penicillin, streptomycin and sodium bicarbonate. It is a complete medium and does not require supplementation with any additional components.